Corporate Investor Profile
In the last 3 years, Novo Holdings A/S has acquired 4 companies.
Novo Holdings A/S’s most common sectors for investment arelife science (46%) and information technology (19%) . The Firm’s most common investment types include secondary buyout (73%) and going private (10%). In total, Novo Holdings A/S has invested in 5 US states and 4 different countries. Its largest (disclosed) acquisition occurred in 2013 when it acquired Xellia Pharmaceuticals AS for $700M.
The Firm’s most common exit type is secondary buyout (100%). Novo Holdings A/S’s largest (disclosed) exit occurred in 2021 when it sold Unchained Labs for $435M.
Join Mergr to view Novo Holdings A/S’s full profile and discover more middle-market corporate investor investors just like it.
M&A Summary
-
M&A Total Activity12
- M&A Buy Activity11
- M&A Sell Activity1
- Total Sectors Invested 5
- Total Countries Invested 4
- M&A Buy/Sell Connections 2
- M&A Advisors 8
Unlimited Searches
